Jena, Germany, August 19, 2026
ZEISS Medical Technology, part of Carl Zeiss Meditec AG, has announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for ZEISS CLINIC 360, an all-in-one, cloud-based and browser-based software solution designed to support ophthalmic clinical workflows. The platform combines diagnostic information, medical records, and practice data into a comprehensive patient view, helping eye-care professionals evaluate disease progression, access relevant clinical information, and support treatment decisions. The company plans to make ZEISS CLINIC 360 available in the United States in early fall 2026, expanding its portfolio of digitally connected ophthalmic solutions.
ZEISS CLINIC 360 Creates a Unified Patient View
ZEISS CLINIC 360 is designed to address the growing volume and complexity of information generated during modern eye care. The software aggregates data from diagnostic imaging devices, electronic medical records (EMRs), and practice management systems to provide clinicians with a consolidated view of individual patients. The platform can display DICOM-enabled diagnostic data from ZEISS systems, including CIRRUS®, CLARUS® and HFA®, as well as compatible third-party devices. Through EMR integration, relevant patient information such as risk factors, family history, allergies, and other clinical details can be brought into the same workflow. By organizing medical and diagnostic information together, ZEISS aims to reduce the time clinicians spend searching across separate systems and make critical information easier to interpret during patient consultations.
Advanced Analytics Support Ophthalmic Decision-Making
The newly cleared platform also uses disease-based summaries, interactive analysis, automated tools, and trend visualization to turn large volumes of clinical information into actionable insights. For example, clinicians monitoring glaucoma can use ZEISS CLINIC 360 to evaluate changes across optical coherence tomography (OCT), intraocular pressure (IOP), and visual field data. Color-coded alerts and trend analysis are designed to help practitioners identify meaningful changes more efficiently and support ongoing disease monitoring. The platform also includes access to the ZEISS Collaborative Care feature, enabling clinicians to securely share cases and reports and seek input from colleagues when consultation is required. These capabilities are intended to streamline ophthalmic workflows while supporting more informed and personalized patient care.
Advertisement
Cloud-Based Platform Expands Digital Eye Care
ZEISS CLINIC 360 is built on the ZEISS Health Data Platform and provides a cloud-based alternative to traditional locally installed data-management systems. Clinicians can access the browser-based solution across locations without requiring local software installation, supporting practices that need greater flexibility and scalability. The platform is offered through a subscription-based model, allowing practices to select configurations aligned with their operational and clinical requirements. ZEISS will continue to offer ZEISS FORUM as an on-premise data-management option for practices that prefer local infrastructure, while CLINIC 360 provides an alternative for organizations seeking cloud connectivity and predictable subscription costs. The FDA 510(k) clearance represents an important regulatory milestone for ZEISS as ophthalmology increasingly adopts connected technologies and digital clinical workflows. By combining clinical data aggregation, advanced analytics, EMR integration, and cloud-based accessibility, ZEISS CLINIC 360 is positioned to help eye-care providers manage complex patient information more efficiently while keeping clinicians focused on personalized care. The development also highlights the continued growth of software-driven medical technology and connected ophthalmic solutions in modern healthcare.
Source: ZEISS press relese
